中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

37 records (took 0.026 seconds)

    한국형 낭충봉아부패병 바이러스 감염 진단용 조성물 및 이를 이용한 진단 방법
    24.
    发明公开
    한국형 낭충봉아부패병 바이러스 감염 진단용 조성물 및 이를 이용한 진단 방법 有权
    用于诊断韩国类型的沙眼病毒的组合物及其诊断方法

    公开(公告)号：KR1020140005458A

    公开(公告)日：2014-01-15

    申请号：KR1020120072679

    申请日：2012-07-04

    Applicant: 대한민국(농림축산식품부 농림축산검역본부장)

    Inventor： 강승원 ,  유미선 ,  노진형 ,  권창희 ,  정석찬

    IPC: C12N15/11 ,  C12Q1/68 ,  C12Q1/04

    CPC classification number: C12Q1/6844 ,  C12N15/11 ,  C12Q1/04

    Abstract: The present invention relates to a primer set for diagnosing Korea type sacbrood virus, and a method for diagnosing Korea type sacbrood virus using the primer set. The primer set for diagnosing Korea type sacbrood virus has an excellent effect of specifically extracting Korea type sacbrood virus from samples of sacbrood virus infection, thereby being used for extracting and diagnosing Korea type sacbrood virus. [Reference numerals] (AA) Lane 1-4 : Sample of honey bee infected with Korea type sacbrood virus; (BB) Lane 5-7 : Sample of honey bee infected with other type sacbrood virus; (CC) Lane 8 : Positive control group; (DD) Lane 9 : Negative control group

    Abstract translation: 本发明涉及用于诊断韩国型囊状病毒的引物组，以及使用引物组诊断韩国型囊状病毒的方法。 用于诊断韩国型sacbrood病毒的引物组具有从sacbrood病毒感染样品中特异性提取韩国型sacbrood病毒的优异效果，用于提取和诊断韩国型sacbrood病毒。 （AA）泳道1-4：用韩国型sacbrood病毒感染的蜂蜜样品; （BB）泳道5-7：用其他类型的囊状病毒感染的蜂蜜样品; （CC）泳道8：阳性对照组; （DD）泳道9：阴性对照组

    톡소플라즈마 원충증 예방 및 치료용 조성물
    25.
    发明公开
    톡소플라즈마 원충증 예방 및 치료용 조성물 无效
    用于预防和治疗粘液病的组合物

    公开(公告)号：KR1020130077278A

    公开(公告)日：2013-07-09

    申请号：KR1020110145900

    申请日：2011-12-29

    Applicant: 대한민국(농림축산식품부 농림축산검역본부장)

    Inventor： 강승원 ,  최세은 ,  노진형 ,  권창희 ,  고경봉

    IPC: A61K39/395 ,  A61P33/00

    CPC classification number: A61K39/3955 ,  A61K2039/552 ,  Y10S424/826

    Abstract: PURPOSE: A composition for toxoplasma strongylosis prevention and treatment is provided to be used on the toxoplasma strongylosis prevention and treatment by lowering infection and removing toxoplasma strongylosis without concern for toxicity and antibiotic resistance. CONSTITUTION: A composition for toxoplasma strongylosis prevention and treatment comprises an immunoglobulin yolk obtained through inoculating the toxoplasma strongylosis antigen to an egg. The antigen comprises an additional adjuvant. The immunoglobulin yolk is included to 260-1350 micrograms/milliliters. The treatment method is to inoculate the composition containing pharmaceutically effective amount of immunoglobulin yolk to a mammal. [Reference numerals] (AA) Survival rate (%)

    Abstract translation: 目的：预防和治疗弓形体弓形虫病的组合物用于通过降低感染和去除弓形体强病毒而不受毒性和抗生素耐药性的预防和治疗弓形虫病。 构成：预防和治疗弓形体强毒素组合物包括通过将强毒素弓形虫病抗原接种到卵中获得的免疫球蛋白卵黄。 抗原包含另外的佐剂。 将免疫球蛋白蛋黄包含在260-1350微克/毫升中。 处理方法是将含有药学有效量的免疫球蛋白蛋白的组合物接种到哺乳动物。 （附图标记）（AA）存活率（％）

    리슈만편모충의 항원을 라텍스 비드에 결합시키는 방법 및 동물의 리슈만편모충증을 진단하는 방법
    27.
    发明公开
    리슈만편모충의 항원을 라텍스 비드에 결합시키는 방법 및 동물의 리슈만편모충증을 진단하는 방법 无效
    将雷公藤抗原与LATEX珠组合的方法及其诊断方法

    公开(公告)号：KR1020120024290A

    公开(公告)日：2012-03-14

    申请号：KR1020100087127

    申请日：2010-09-06

    Applicant: 대한민국(농림축산식품부 농림축산검역본부장)

    Inventor： 강승원 ,  최세은 ,  권창희 ,  이희수 ,  정갑수 ,  정석찬

    IPC: G01N33/544 ,  G01N33/569

    Abstract: PURPOSE: A method for binding Leishmania infantum antigen to latex beads is provided to enable simple and cheap diagnosis without expensive equipment. CONSTITUTION: A method for binding Leishmania infantum(ATCC 50134) antigen to latex beads comprises: a step of the Leishmania infantum antigen in 45mM~55mM HEPES(4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) and 145-155mM NaCl buffer in a concentration of 1.45mg/ml-1.55mg/ml; a step of reacting the latex beads into the diluted antigen at 35-39°C for 0.5-1.5 hours and then reacting at 3-5°C for 8-12 hours; a step of centrifuging the reacted antigen at 5,000rpm-7000rpm for 15-25 minutes; and a step of treating 10% BSA(Bovine Albumin Serum) for 2.5-3.5 hours.

    Abstract translation: 目的：提供一种将利什曼原虫婴幼儿抗原结合到乳胶珠上的方法，以便在没有昂贵的设备的情况下进行简单而便宜的诊断。 构成：将利什曼原虫（ATCC 50134）抗原结合到乳胶珠的方法包括：在45mM〜55mM HEPES（4-（2-羟乙基）-1-哌嗪乙磺酸）和145-155mM NaCl缓冲液中的利什曼原虫婴幼儿抗原的步骤 浓度为1.45mg / ml-1.55mg / ml; 将乳胶珠在35-39℃下反应0.5-1.5小时，然后在3-5℃下反应8-12小时; 以5000rpm-7000rpm离心反应的抗原15-25分钟的步骤; 以及将10％BSA（牛白蛋白血清）处理2.5-3.5小时的步骤。

    소 타일레리아병의 약독화 백신
    29.
    发明公开
    소 타일레리아병의 약독화 백신 有权
    牛血清病毒灭绝疫苗

    公开(公告)号：KR1020030053856A

    公开(公告)日：2003-07-02

    申请号：KR1020010083879

    申请日：2001-12-24

    Applicant: 대한민국(농림축산식품부 농림축산검역본부장)

    Inventor： 강승원 ,  최은진 ,  정우석

    IPC: A61K39/002

    Abstract: PURPOSE: An attenuated vaccine prepared by isolating a Theileria sergenti Sungwhan stock from Haemaphysalis longicornis and then attenuating it is provided. The vaccine has recognizable specific protection property and thus can be effectively used in the prevention of bovine theileriosis. CONSTITUTION: An attenuated vaccine is prepared by the steps of: recovering Haemaphysalis longicornis imagoes from bovines infected with theileriosis; infecting a rabbit with the Haemaphysalis longicornis imagoes for 6 to 7 days; and aseptically collecting salivary gland from the collected Haemaphysalis longicornis imagoes. The vaccine is formed into an injectable formulation.

    Abstract translation: 目的：提供一种减毒疫苗，通过从长尾by中分离出The a han han han han han han han then then vaccine vaccine vaccine vaccine vaccine。。。。 该疫苗具有可识别的特异性保护性，因此可有效地用于预防牛皮层病。 构成：通过以下步骤制备减毒疫苗：从感染苔藓病的牛中回收Haemaphysalis longicornis成虫; 用Haemaphysalis longicornis成像感染兔子6至7天; 并从收集的痢疾长角猿成虫中无菌收集唾液腺。 疫苗形成可注射制剂。

Patent Agency Ranking